Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Enhancement of Radiation Effects by Chemotherapy

Enhancement of Radiation Effects by Chemotherapy regimens, administered in pulses or courses, is lacking. Since this article was written, there have been a number of preliminary reports on combined multiple drug and radiotherapy for radiation-responsive tumors which tend to disseminate widely, including Wilms's tumor, rhabdomyosarcoma, Ewing's sarcoma, and Stage III Hodgkin's disease. Treatment of these tumors is directed toward (a) reduction of tumor volume in the primary site and (b) elimination of occult metastases. In the past, the lack of a systematized approach t? treat~ent and reporting in too many instances has resulted m considerable confusion regarding the efficacy of combining cherno- and radiotherapy. A gradual recognition of the need for organized protocols and cooperative clinical trials will undoubtedly escalate the collection of meaningful data for those malignant diseases which are responsive to both modes of treatment. As Dr. Vermund indicates, further progress depends upon the development of chemotherapeutic agents which will enhance the effect of irradiation in resistant tumors. LILLIAN M. FULLER, M. D. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Radiology Radiological Society of North America, Inc.

Enhancement of Radiation Effects by Chemotherapy

Radiology , Volume 106: 424 – Feb 1, 1973

Loading next page...
 
/lp/radiological-society-of-north-america-inc/enhancement-of-radiation-effects-by-chemotherapy-7Ol01MYkD2

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Radiological Society of North America, Inc.
Copyright
Copyright © February 1973 by Radiological Society of North America
ISSN
1527-1315
eISSN
0033-8419
Publisher site
See Article on Publisher Site

Abstract

regimens, administered in pulses or courses, is lacking. Since this article was written, there have been a number of preliminary reports on combined multiple drug and radiotherapy for radiation-responsive tumors which tend to disseminate widely, including Wilms's tumor, rhabdomyosarcoma, Ewing's sarcoma, and Stage III Hodgkin's disease. Treatment of these tumors is directed toward (a) reduction of tumor volume in the primary site and (b) elimination of occult metastases. In the past, the lack of a systematized approach t? treat~ent and reporting in too many instances has resulted m considerable confusion regarding the efficacy of combining cherno- and radiotherapy. A gradual recognition of the need for organized protocols and cooperative clinical trials will undoubtedly escalate the collection of meaningful data for those malignant diseases which are responsive to both modes of treatment. As Dr. Vermund indicates, further progress depends upon the development of chemotherapeutic agents which will enhance the effect of irradiation in resistant tumors. LILLIAN M. FULLER, M. D.

Journal

RadiologyRadiological Society of North America, Inc.

Published: Feb 1, 1973

There are no references for this article.